Rahway: Merck, known as MSD outside the United States and Canada, has announced that the company has received approval from ...
Sotatercept-csrk is approved for improving exercise capacity and reducing clinical worsening in PAH patients, following FDA ...
Rahway, New Jersey Tuesday, October 28, 2025, 12:00 Hrs [IST] ...
WINREVAIR is the subject of a licensing agreement with Bristol Myers Squibb.
Manipur has witnessed a sharp rise in dengue infections this year, with health officials sounding the alarm and deploying intensified preventive actions.
For many, hair loss is an inevitable part of getting older — but thanks to new breakthroughs, it doesn’t have to be ...
Sportschosun on MSN
Hepatitis B Patients' Liver Cancer Prediction, Development of a New Model...82% accuracy
A new model has been developed that can more accurately predict the risk of liver cancer in hepatitis B patients. A research ...
NASP data highlight reduction in disease burden among people living with uncontrolled goutGamifant (emapalumab) data showed response rates in ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced plans to present new research from the company’s cardio-pulmonary portfolio and pipeline at the American Heart ...
Q3 2025 Earnings Call October 24, 2025 8:30 AM EDTCompany ParticipantsThomas Larsen - Head of Investor RelationsPaul Hudson - CEO ...
Two-thirds of American men will have noticeable hair loss by age 35, with some 85% having significantly thinning hair by age ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback